Anal Fistula Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Anal Fistula clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

Perianal Fistula Due to Crohn's Disease
Direct Biologics, LLC36 enrolled3 locationsNCT06918808
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Phase 1

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease

Perianal Fistula Due to Crohn's DiseaseFistula in Ano
CryoCord Sdn Bhd5 enrolled1 locationNCT05039411
Recruiting
Phase 1

Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease

Crohn's DiseasesActive Anal FistulaUpadacitinib
Sixth Affiliated Hospital, Sun Yat-sen University27 enrolled1 locationNCT06902987
Recruiting

Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells

Crohn DiseaseAnal Fistula
Nantes University Hospital20 enrolled1 locationNCT05974280
Recruiting
Phase 1

Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula

Crohn's DiseaseAnal FistulaComplex Perianal Fistulas
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.8 enrolled1 locationNCT06429241
Recruiting
Not Applicable

Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study

Perianal Fistula Due to Crohn's DiseasePerianal FistulaPerianal Abscess
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)40 enrolled1 locationNCT06446635
Recruiting
Phase 4

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Crohn DiseasePerianal Fistula Due to Crohn's DiseaseInfliximab+2 more
Asan Medical Center86 enrolled1 locationNCT06051253